APA (7th ed.) Citation

JD, H., S, L., MR, L., GI, R., Jr, S. C., & FA, G. (2003). First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: Phase II trial. Clinical lymphoma, 4(1), 36. https://doi.org/10.3816/clm.2003.n.012

Chicago Style (17th ed.) Citation

JD, Hainsworth, Litchy S, Lamb MR, Rodriguez GI, Scroggin C. Jr, and Greco FA. "First-line Treatment with Brief-duration Chemotherapy Plus Rituximab in Elderly Patients with Intermediate-grade Non-Hodgkin's Lymphoma: Phase II Trial." Clinical Lymphoma 4, no. 1 (2003): 36. https://doi.org/10.3816/clm.2003.n.012.

MLA (9th ed.) Citation

JD, Hainsworth, et al. "First-line Treatment with Brief-duration Chemotherapy Plus Rituximab in Elderly Patients with Intermediate-grade Non-Hodgkin's Lymphoma: Phase II Trial." Clinical Lymphoma, vol. 4, no. 1, 2003, p. 36, https://doi.org/10.3816/clm.2003.n.012.